The UCLPartners Board has announced the appointment of Dr Charlie Davie as Managing Director of UCLPartners after an extensive international search process.
Charlie has been Managing Director of the UCLPartners Academic Health Science Network since April 2014 and interim Managing Director of UCLPartners since the retirement of Professor Sir David Fish in September 2016.
Charlie brings extensive clinical and academic experience to this role with an impressive career as a consultant neurologist and as an honorary senior lecturer at UCL’s Institute of Neurology. As the lead for the reconfiguration of hyper acute stroke units in London, Charlie has a strong track record in partnership working and delivering improvements on behalf of whole populations. In addition to his local leadership and influence, Charlie has held several national advisory roles, most recently providing expert opinion on the Accelerated Access Review working with the Office of Life Sciences and NHS England.
Professor The Lord Ajay Kakkar, Chair of UCLPartners, said: “The Board is delighted to appoint Dr Charlie Davie as Managing Director of UCLPartners. He brings to this challenging role a deep commitment to patients, powerful insight to the needs of our population and a significant track record of leadership in research, quality improvement and innovation. Under Charlie’s leadership I am confident that UCLPartners will continue to add great value to the exceptional organisations across our partnership and to the wider healthcare system.”
Commenting on his appointment, Charlie said: “I feel truly honored to be taking on this role. Working with our world class partners and the amazing team of people within UCLPartners is an immense privilege. Together, we will continue to focus on how we can continue to make the greatest contribution to improving the health and wellbeing of our patients and population while we share and learn from the best people and health systems across the world.”